Therefore, this hormone should undergo further clinical studies, particularly involving individuals with obesity, to determine whether PYY may affect fat content and, consequently, the development of obesity and its complications. The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.